Brevan Howard Capital Management’s Edgewise Therapeutics EWTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$178K	Buy	+13,561	New	+$178K	﹤0.01%	1642
2025 Q1	–	Sell	-25,346	Closed	-$677K	–	1209
2024 Q4	$677K	Buy	25,346 +14,095	+125%	+$376K	﹤0.01%	502
2024 Q3	$300K	Buy	+11,251	New	+$300K	﹤0.01%	805